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Sir,
We have read with interest the paper by Bui and
colleagues regarding the clinical results of the systematic
implementation of strategies to minimise the blood loss and
transfusion requirements in hepatic resection, designated as
the minimal blood loss programme (MBL) [1]. We should
like to comment on some aspects of the paper.
1). The fact that all resections have been performed by
the same surgeon gives strength to the data, whereas the
wide period of time examined (20 years) might have intro-
duced some bias. The transfusion criteria applied in the
study (if any) are not mentioned in the paper, but as they
have changed substantially over the last 20 years, with the
30/10 rule progressively abandoned, their probable influ-
ence on the transfusion rate should not be ignored.
Nowadays, restrictive transfusion criteria, while safe for the
patient, are a milestone in an integrated blood conserva-
tion programme (IBCP) [2]. Surgical techniques and
instruments have also changed during this period. For
example, the ultrasonic dissector (Cavitron) was used in 23
patients (47%) in the pre-MBL group, although it is not
stated when this device was introduced. However, as shown
in Figure 1 of Bui’s paper, blood loss in the 31 patients
operated between 1987–1990 seems to be substantially less
than that of the 17 patients who underwent hepatic resec-
tion between 1980–1986. If the use of the cavitron rather
than the learning curve accounts for this difference [3, 4],
as can be presumed from data in Table 3, then these two
sub-groups might have been studied separately.
2). Among the patient demographics and clinical data
we could not find records of either weight and height,
which are important for blood volume determination, or
preoperative haemoglobin concentration (Hb), which is
known to be a good predictor of perioperative transfusion
requirements, especially when used in combination with
the estimated blood loss [5]. Hence, whenever possible,
preoperative pharmacological treatment of anaemia (iron,
human recombinant erythropoietin (EPO)) should be
implemented as a part of an IBCP to produce a higher pre-
operative Hb level and/or facilitate preoperative autologous
blood transfusion (PABD) [6, 7].
3). The use of autologous blood (autotransfusion) is an
important strategy in an IBCP. In this study, Preoperative
autologous blood donation (PABD) and intraoperative
autotransfusion (IAT) have been used. Regarding PABD,
neither the number of patients entered in the programme
(though it seems to be 56: Figure 2) nor the number of units
requested, deposited, and transfused were stated. Regarding
IAT, although it has been shown to be efficacious in hepa-
tectomy for hepatocellular carcinoma [8], it was used in
only 21 patients. Nevertheless, it should have been stated
whether the patients with IAT had benign tumours or
received specific measures to eliminate cancer cells, such as
filtration and/or irradiation [9, 10]. In addition, it is well
known that only 50–60% of shed blood can be saved by the
use of a cell saver. Therefore, at least the non-saved blood
volume had to be considered as blood loss, and the volume
of saved shed blood had to be appropriately converted into
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units and added to the PABD units to give the total autol-
ogous blood transfusion rate. Since this information is not
given in the paper, there is no real way of knowing either
what the ‘mean # of units of AB transfused’ means or what
was the contribution of autotransfusion to homologous
blood avoidance. Again, a sub-group analysis is warranted.
We are now conducting a prospective study on similar
patients comparing postoperative outcomes in those pro-
posed for entry into a PABD programme (admitted and
rejected) and those with standard homologous transfusion
therapy. Patients who died, underwent re-operation or
emergency operation, or were preoperatively transfused are
excluded. We also exclude those who are first transfused
after the development of a postoperative complication
because our objective is to establish a correlation between
homologous blood transfusions and postoperative compli-
cations, and not the other way around. Our results indicate
that homologous transfusion increases the incidence of
postoperative complications (55 vs. 8% for homologous
and autologous blood, respectively), the length of ICU stay
(5 vs. 1 days) and the overall length of hospital stay (39 vs.
10 days). Although preliminary, our data suggest that in
these patients PABD is an excellent blood conservation
strategy which improves outcome, and its use should be
encouraged. [11].
4). In Bui’s study the implementation of a MBL pro-
gramme has led to a significant reduction in the overall
morbidity rate, although we think its high incidence
(36.7% in pre-MBL vs. 14.7% in MBL) merits a more
detailed description of ‘other morbidity’. Of major interest
is the remarkable threefold reduction in the incidence of
sepsis, which might be the main factor contributing to the
lower mortality rate. In addition to the 5-fold reduction in
the number of homologous blood units transfused, several
other factors may have played a role in this lower incidence
of sepsis, including a more effective antibiotic prophylaxis,
the anti-inflammatory effect of aprotinin and the increas-
ing use of early enteral nutrition. Other strategies such as
perioperative normothermia or hyperoxic ventilation
should be also considered to decrease further the risk of
postoperative  infection.
Finally, we really believe that the paper by Bui and
colleagues has clearly shown how an integrated blood
conservation programme, rather than just a minimal blood
loss programme, may reduce the morbidity and mortality
rates associated with this aggressive surgery. This paper
gives strong support to the so-called ‘culture of bloodless
surgery’, for which a multidisciplinary approach is crucial.
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